Skip to main content

Familial Cancer

Ausgabe 1/2025

Inhalt (27 Artikel)

Overlap syndrome of hereditary hemorrhagic telangiectasia and juvenile polyposis syndrome: ten years follow-up-case series and review of literature

  • Original Article

Maria Laura Gonzalez, Carolina Vazquez, Maria J. Argüero, Juan P. Santino, Ana Braslavsky, Marcelo M. Serra

Mainstreaming cancer genetics: feasibility of an advanced nurse practitioner-led service diagnosing Lynch syndrome from colorectal cancer in Ireland

  • Original Article

Mechelle Loughrey, Lauren V. O’Connell, Lynda McSorley, Sean Martin, Ann Hanly, Des C. Winter, Ian M. Frayling, Kieran Sheahan, Rory Kennelly

Germline pathogenic variants in RNF43 in patients with and without serrated polyposis syndrome

  • Open Access
  • Original Article

Heidi Hesselø Brinch, Anna Byrjalsen, Zuzana Lohse, Andreas Ørslev Rasmussen, John Gásdal Karstensen, Britta Schlott Kristiansen, Anne Marie Jelsig

BRCAIndica: a resource for ACMG/AMP classified BRCA1 and BRCA2 variants

  • Brief Report

Aastha Vatsyayan, R. I. Anu, Prerika Mathur, Divya Uchil, Ashish Joshi, Aradhana Dwivedi, Bhawna Sirohi, Aju Mathew, Dileep Damodaran, Soumya Surath Panda, Spoorthy Kolluri, Shaji K. Ayillath, Deepak Amalnath, Gomathi Shankar, Kavita Pandhare, Vinod Scaria

Prevalence of cardiometabolic outcomes in women who underwent salpingo-oophorectomy to prevent hereditary breast and ovarian cancer: a meta-analysis

  • Original Article

Francisco Cezar Aquino de Moraes, Lucca Dal Moro, Maria Eduarda Cavalcanti Souza, Anna Luíza Soares de Oliveira Rodrigues, Vitor Kendi Tsuchiya Sano, Bárbara Ferraz Barbosa, Lucas Gama Pacheco, Daniel Ferreira Cunha, Otávio Luiz de Queiroz, Dilma do Socorro Moraes de Souza, Danielle Feio, Carlos Stecca, Rommel Mario Rodríguez Burbano

The genetic landscape of Lynch syndrome in the Israeli population

  • Open Access
  • Original Article

Aasem Abu Shtaya, Sofia Naftaly Nathan, Inbal Kedar, Eitan Friedman, Elizabeth Half, Gabi Lidzbarsky, Gili Reznick Levi, Ido Laish, Lior Katz, Lily Bazak, Lilach Peled Peretz, Lina Basel Salmon, Liza Douiev, Marina Lifshitc Kalis, Menachem Schechter, Michal Barzily-Rokni, Nadra Nasser Samra, Naim Abu-Freha, Ofir Hagari-Bechar, Ori Segol, Samar Mattar, Sarit Farage Barhom, Shikma Mordechai, Shiri Shkedi Rafid, Stavit A. Shalev, Tamar Peretz-Yablonski, Zohar Levi, Revital Bruchim, Chana Vinkler, Rinat Bernstein-Molho, Sari Lieberman, Yael Goldberg

Hereditary breast and ovarian cancer genetic testing in unselected patients: example of private supplementation of public healthcare service

  • Brief Report

Francesca Fiorentino, Giovanni Innella, Federica Balducci, Laura Marullo, Giulia Lanzoni, Sara Miccoli, Laura Cardarelli, Daniela Turchetti, Sergio Tempesta

A family-based approach to cascade genetic testing in a pediatric cancer genetics clinic

  • Original Article

Rida Haider, Lauren Desrosiers-Battu, Sarah Scollon, Pawel Stankiewicz, Philip J. Lupo, Sharon E. Plon

Cascade genetic testing in hereditary cancer: exploring the boundaries of the Italian legal framework

  • Original Article

Liliana Varesco, Francesco Di Tano, Juri Monducci, Stefania Sciallero, Daniela Turchetti, Claudia Bighin, Giulia Buzzatti, Irene Giannubilo, Lucia Trevisan, Linda Battistuzzi

Sarcomas arising in MEN1 patients: demonstrating LOH of the MEN1 locus and loss of menin expression

  • Original Article

Rachel S. van Leeuwaarde, Thorvardur R. Halfdanarson, Shwetha M. Sudhakar, Ruud W. J. Meijers, Andrew L. Folpe, Lodewijk A. A. Brosens

Recurrent paraneoplastic nephrotic syndrome; insights from a Lynch syndrome patient with multiple malignancies

  • Short Communication

Myrthe A. de Jong, Marije Slingerland, Lukas J. A. C. Hawinkels, Maartje Nielsen, Augustinus S. L. P. Crobach, Eveline S. M. de Jonge-Muller, Antonius J. Rabelink, Alexandra M. J. Langers

Haplotype analysis detects MLH1 founder variant in Indian Lynch syndrome patient cohort

  • Original Paper

Harsh Sheth, Jyoti Sadhwani, Abhinav Jain, S. G. Thenral, Vedam Ramprasad, D. Timothy Bishop

The challenge of preventing gastric cancer in patients under surveillance for familial adenomatous polyposis

  • Open Access
  • Brief Report

Hicham Bouchiba, Arthur S. Aelvoet, Nicole C. T. van Grieken, Lodewijk A. A. Brosens, Barbara A. J. Bastiaansen, Evelien Dekker

Progress report on multiple endocrine neoplasia type 1

  • Open Access
  • Review

Reut Halperin, Amit Tirosh

Correction: Benign tumors and non-melanoma skin cancers in patients with fanconi anemia

  • Open Access
  • Correction

Aura Enache, Bia Sajjad, Burak Altintas, Neelam Giri, Lisa J. McReynolds, Edward W. Cowen

Correction: Outcomes of retesting in patients with previously uninformative cancer genetics evaluations

  • Correction

Shenin A. Sanoba, Erika S. Koeppe, Michelle F. Jacobs, Elena M. Stoffel

Case review of perivascular epithelioid cell tumor occurring in patients with Li-Fraumeni syndrome

  • Brief Report

Natsuno Abe, Fumito Yamazaki, Hanako Tsujikawa, Ryosuke Kasuga, Nobuhito Taniki, Hiroyuki Shimada

Thirty-year compliance with a surveillance program for patients with familial adenomatous polyposis

  • Original Article

Boris Cleret de Langavant, Jéremie H. Lefèvre, Julie Metras, Antoine Dardenne, Lauren V. O’Connell, Maxime Collard, Yann Parc

Myelodysplastic syndrome with dual germline RUNX1 and DDX41 variants: a rare genetic predisposition case

  • Brief Report

Virginia Bove, Maria Noel Spangenberg, Carolina Ottati, Lucia Vázquez, Ana I. Catalán, Sofía Grille

Identification of a germline deep intronic PTEN-deletion leading to exonization through whole genome and targeted RNA sequencing

  • Brief Report

Morgane Boedec, Camille Aucouturier, Mathias Cavaillé, Raphaël Leman, Laurent Castéra, Hélène Delhomelle, Nancy Uhrhammer, Virginie Bernard, Sophie Giraud, Eulalie Lasseaux, Natalie Jones, Marie Bidart, Nadia Boutry-Kryza, Catherine Noguès, Chrystelle Colas, Christine Maugard, Sophie Krieger, Ahmed Bouras

New RPS20 gene variant in colorectal cancer diagnosis: insight from a large series of patients

  • Original Article

Julie Amiot, Lara Gubeljak, Agathe Fontaine, Denis Smith, Isabelle Mortemousque, Nathalie Parodi, Jacques Mauillon, Edwige Kasper, Stéphanie Baert-Desurmont, Julie Tinat, Claude Houdayer

CHEK2-related breast cancer: real-world challenges

  • Original Article

Luiza N. Weis, Brittany L. Bychkovsky, Adela Rodríguez Hernandez, Romualdo Barroso-Sousa, Renata L. Sandoval

A novel likely pathogenic germline variant in CDKN1B in a patient with MEN4 and medullary thyroid cancer

  • Brief Report

Fernández Mercè, Queralt Asla, Francisco J. Illana, Fusté Victòria, Hernández-Losa Javier, Sesé Marta, Carmela Iglesias, Susan M. Webb, Anna Aulinas

Healthcare provider-mediated cascade testing of Lynch syndrome to at-risk family members: an interview study

  • Original Article

Serene Ong, Zi Yang Chua, Jeanette Yuen, Jianbang Chiang, Zhang Zewen, Joanne Ngeow, Tamra Lysaght

Addressing uncertainty in hereditary colorectal cancer: the role of a regional expert multidisciplinary team meeting

  • Open Access
  • Brief Report

Avani Varde, Terri McVeigh, Vicky Cuthill, Angela F. Brady, Bianca DeSouza, Andrew Latchford, Kevin J. Monahan

Neu im Fachgebiet Onkologie

Krebsscreeningprogramme erreichen Menschen mit kognitiver Beeinträchtigung schlechter

Daten aus den Niederlanden zeigen, dass Krebsfrüherkennungsmaßnahmen für Menschen mit Störungen der Intelligenzentwicklung häufig nicht zugänglich sind. Wie kann diese Lücke geschlossen werden?

Perkutane Ablation – ungenutztes Potenzial für die Schmerztherapie?

Geht es nach US-Versicherungsdaten, ist die perkutane Ablation eine vorteilhafte, aber zu selten genutzte Option in der Schmerzlinderung von Personen mit bestimmten Tumoren. Wichtige Fragen bleiben allerdings unbeantwortet.

Reduzieren Kälte und Kompression die CIPN-Gefahr in den Händen?

Ergebnisse der deutschen POLAR-Studie sprechen dafür, dass kühlende oder komprimierende Handschuhe das Risiko für eine Taxan-induzierte periphere Neuropathie senken können. Ein paar Fragen bleiben aber offen.

BCG-Therapie kann die Zystektomie ersparen

Patienten und Patientinnen mit hoch- oder äußerst riskantem nicht muskelinvasivem Blasenkrebs können mithilfe von BCG-Instillationen die radikale Zystektomie mitunter vermeiden. Muss die Blase später doch entfernt werden, darf der rechte Zeitpunkt nicht verpasst werden.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.